Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Game Plan: Merck Is Right for This Market
CNBC
Saturday, October 18, 2008 - 12:56pm
tags:
Genzyme Nears Key FDA Panel Meeting
The Street
Saturday, October 18, 2008 - 12:53pm
tags:
Alexza completes enrollment for second Phase III acute agitation trial
Pharmaceutical Business Review
Saturday, October 18, 2008 - 12:44pm
tags:
Ocimum Biosolutions wins two new US patents
Pharmaceutical Business Review
Saturday, October 18, 2008 - 12:44pm
tags:
Schering-Plough expected to report lower profit
MarketWatch
Saturday, October 18, 2008 - 12:29pm
tags:
Merck expands cholesterol study for faster results
Yahoo/AP
Saturday, October 18, 2008 - 12:28pm
tags:
Pfizer Finds Redemption
Forbes
Saturday, October 18, 2008 - 12:27pm
tags:
Bioheart, Inc. Announces Additional Funding Support
Yahoo
Saturday, October 18, 2008 - 12:27pm
tags:
Bioheart, Inc. Reports Receipt of Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements
Yahoo
Saturday, October 18, 2008 - 12:26pm
tags:
Neose Technologies' Common Stock Continues Listing on Nasdaq Global Market Pending Appeal Hearing
Yahoo
Saturday, October 18, 2008 - 12:22pm
tags:
Pfizer to Pay $894 Million to Resolve Celebrex, Bextra Lawsuits
Bloomberg
Friday, October 17, 2008 - 9:58am
tags:
Sanofi Zooms on Reported Delay for Lilly Blood Thinner
WSJ Online
Friday, October 17, 2008 - 9:39am
tags:
Merck Targets Gardasil Vaccine to Women Least Likely to Benefit
Bloomberg
Friday, October 17, 2008 - 9:38am
tags:
Daiichi Sankyo Acquires 20% of Ranbaxy Laboratories
Bloomberg
Friday, October 17, 2008 - 9:37am
tags:
Lance Armstrong and Bill Clinton Help Fred Baron Get Tysabri
WSJ Online
Friday, October 17, 2008 - 9:15am
tags:
Even Fatter Yields for Pfizer; M&A Targets in the Sector
Seeking Alpha
Friday, October 17, 2008 - 9:14am
tags:
Genentech's Raptiva Must Carry Warning on Infections
Bloomberg
Friday, October 17, 2008 - 9:13am
tags:
Why It's Time to Buy More Immunogen
Seeking Alpha
Friday, October 17, 2008 - 9:12am
tags:
Dendreon Gets Another Analyst Thumbs-Down
Seeking Alpha
Friday, October 17, 2008 - 9:12am
tags:
Valeant Pharmaceuticals receives $125 million payment from GlaxoSmithKline under partnership
Yahoo/AP
Friday, October 17, 2008 - 9:10am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information